Cleaning Umbilical Cord With Chlorhexidine Lowers Mortality

This article originally appeared here.
Share this content:
Cleaning Umbilical Cord With Chlorhexidine Lowers Mortality
Cleaning Umbilical Cord With Chlorhexidine Lowers Mortality

MONDAY, March 9, 2015 (HealthDay News) -- Using chlorhexidine to clean the umbilical cords of infants born outside of a hospital lowers infant infection and death rates in developing countries, according to a review published online March 5 in The Cochrane Library.

"Based on our review, using chlorhexidine to clean the umbilical cord saves newborn babies lives," lead researcher Anju Sinha, M.D., Ph.D., of the Indian Council of Medical Research in New Delhi, said in a journal news release. The findings were based on 12 clinical trials, some of them conducted in Africa, Southeast Asia, and South America. "The greatest benefits were seen in the Southeast Asian studies," Sinha said. "The results from African studies are less convincing, so we would like to see whether the results from ongoing trials in Zambia and Tanzania can substantiate this evidence."

The review concluded that cleaning umbilical cords with chlorhexidine reduced the risk of infections and the number of infant deaths by 12 percent, compared with keeping cords dry. Use of the antiseptic led to a 50 percent reduction in the number of newborns with swelling of the cord stump that's commonly caused by bacterial infections.

The antiseptic can be applied as a gel, wash, or powder, the study authors said in the news release. In maternity care, chlorhexidine can be used as a vaginal disinfectant to prevent the spread of bacteria from mother to infant, or to clean a newborn's skin or umbilical cord.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »